Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants
- PMID: 24269108
- PMCID: PMC3959199
- DOI: 10.1016/S0140-6736(13)61836-X
Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants
Abstract
Background: Body-mass index (BMI) and diabetes have increased worldwide, whereas global average blood pressure and cholesterol have decreased or remained unchanged in the past three decades. We quantified how much of the effects of BMI on coronary heart disease and stroke are mediated through blood pressure, cholesterol, and glucose, and how much is independent of these factors.
Methods: We pooled data from 97 prospective cohort studies that collectively enrolled 1·8 million participants between 1948 and 2005, and that included 57,161 coronary heart disease and 31,093 stroke events. For each cohort we excluded participants who were younger than 18 years, had a BMI of lower than 20 kg/m(2), or who had a history of coronary heart disease or stroke. We estimated the hazard ratio (HR) of BMI on coronary heart disease and stroke with and without adjustment for all possible combinations of blood pressure, cholesterol, and glucose. We pooled HRs with a random-effects model and calculated the attenuation of excess risk after adjustment for mediators.
Findings: The HR for each 5 kg/m(2) higher BMI was 1·27 (95% CI 1·23-1·31) for coronary heart disease and 1·18 (1·14-1·22) for stroke after adjustment for confounders. Additional adjustment for the three metabolic risk factors reduced the HRs to 1·15 (1·12-1·18) for coronary heart disease and 1·04 (1·01-1·08) for stroke, suggesting that 46% (95% CI 42-50) of the excess risk of BMI for coronary heart disease and 76% (65-91) for stroke is mediated by these factors. Blood pressure was the most important mediator, accounting for 31% (28-35) of the excess risk for coronary heart disease and 65% (56-75) for stroke. The percentage excess risks mediated by these three mediators did not differ significantly between Asian and western cohorts (North America, western Europe, Australia, and New Zealand). Both overweight (BMI ≥25 to <30 kg/m(2)) and obesity (BMI ≥30 kg/m(2)) were associated with a significantly increased risk of coronary heart disease and stroke, compared with normal weight (BMI ≥20 to <25 kg/m(2)), with 50% (44-58) of the excess risk of overweight and 44% (41-48) of the excess risk of obesity for coronary heart disease mediated by the selected three mediators. The percentages for stroke were 98% (69-155) for overweight and 69% (64-77) for obesity.
Interpretation: Interventions that reduce high blood pressure, cholesterol, and glucose might address about half of excess risk of coronary heart disease and three-quarters of excess risk of stroke associated with high BMI. Maintenance of optimum bodyweight is needed for the full benefits.
Funding: US National Institute of Health, UK Medical Research Council, National Institute for Health Research Comprehensive Biomedical Research Centre at Imperial College Healthcare NHS Trust, Lown Scholars in Residence Program on cardiovascular disease prevention, and Harvard Global Health Institute Doctoral Research Grant.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Figures



Comment in
-
Overweight, obesity, and outcomes: fat mass and beyond.Lancet. 2014 Mar 15;383(9921):935-6. doi: 10.1016/S0140-6736(13)62076-0. Epub 2013 Nov 22. Lancet. 2014. PMID: 24269110 No abstract available.
-
[Increased BMI: Which effect do additional risk factors have? - Obese patients: Additional risk factors are highly involved].Dtsch Med Wochenschr. 2014 May;139(21):1092. doi: 10.1055/s-0033-1353904. Epub 2014 May 7. Dtsch Med Wochenschr. 2014. PMID: 24806221 German. No abstract available.
-
Metabolic mediators of body-mass index and cardiovascular risk.Lancet. 2014 Jun 14;383(9934):2042-2043. doi: 10.1016/S0140-6736(14)60991-0. Lancet. 2014. PMID: 24931685 No abstract available.
-
Metabolic mediators of body-mass index and cardiovascular risk.Lancet. 2014 Jun 14;383(9934):2042. doi: 10.1016/S0140-6736(14)60990-9. Lancet. 2014. PMID: 24931686 No abstract available.
-
Metabolic mediators of body-mass index and cardiovascular risk--authors' reply.Lancet. 2014 Jun 14;383(9934):2043-2044. doi: 10.1016/S0140-6736(14)60992-2. Lancet. 2014. PMID: 24931687 No abstract available.
-
Re: Mediators of the Effect of Body Mass Index on Coronary Heart Disease.Epidemiology. 2016 May;27(3):e13-4. doi: 10.1097/EDE.0000000000000442. Epidemiology. 2016. PMID: 26808599 No abstract available.
-
The Authors Respond.Epidemiology. 2016 May;27(3):e14-5. doi: 10.1097/EDE.0000000000000443. Epidemiology. 2016. PMID: 26808603 Free PMC article. No abstract available.
Similar articles
-
Mediators of the effect of body mass index on coronary heart disease: decomposing direct and indirect effects.Epidemiology. 2015 Mar;26(2):153-62. doi: 10.1097/EDE.0000000000000234. Epidemiology. 2015. PMID: 25643095
-
Impact of blood pressure, cholesterol and glucose in the association between adiposity measures and coronary heart disease and stroke among Iranian population.Clin Nutr. 2018 Dec;37(6 Pt A):2060-2067. doi: 10.1016/j.clnu.2017.09.023. Epub 2017 Oct 6. Clin Nutr. 2018. PMID: 29042128
-
Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM2.5, BC, NO2, and O3: An Analysis of European Cohorts in the ELAPSE Project.Res Rep Health Eff Inst. 2021 Sep;2021(208):1-127. Res Rep Health Eff Inst. 2021. PMID: 36106702 Free PMC article.
-
Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons.Arch Intern Med. 2007 Sep 10;167(16):1720-8. doi: 10.1001/archinte.167.16.1720. Arch Intern Med. 2007. PMID: 17846390 Review.
-
Interventions for weight loss in people with chronic kidney disease who are overweight or obese.Cochrane Database Syst Rev. 2021 Mar 30;3(3):CD013119. doi: 10.1002/14651858.CD013119.pub2. Cochrane Database Syst Rev. 2021. PMID: 33782940 Free PMC article.
Cited by
-
Toxicological safety evaluation of Qin-Zhi-Zhu-Dan formula in rats during the treatment and recovery periods.Front Pharmacol. 2022 Aug 25;13:987997. doi: 10.3389/fphar.2022.987997. eCollection 2022. Front Pharmacol. 2022. PMID: 36091824 Free PMC article.
-
Feasibility of body roundness index for identifying a clustering of cardiometabolic abnormalities compared to BMI, waist circumference and other anthropometric indices: the China Health and Nutrition Survey, 2008 to 2009.Medicine (Baltimore). 2016 Aug;95(34):e4642. doi: 10.1097/MD.0000000000004642. Medicine (Baltimore). 2016. PMID: 27559964 Free PMC article.
-
Prediction of Cardiovascular Events by Pulse Waveform Parameters: Analysis of CARTaGENE.J Am Heart Assoc. 2022 Sep 6;11(17):e026603. doi: 10.1161/JAHA.122.026603. Epub 2022 Sep 3. J Am Heart Assoc. 2022. PMID: 36056725 Free PMC article.
-
Body Mass Index Measured Repeatedly over 42 Years as a Risk Factor for Ischemic Stroke: The HUNT Study.Nutrients. 2023 Feb 28;15(5):1232. doi: 10.3390/nu15051232. Nutrients. 2023. PMID: 36904231 Free PMC article.
-
Visceral adiposity index is a better predictor of unhealthy metabolic phenotype than traditional adiposity measures: results from a population-based study.Public Health Nutr. 2019 Jun;22(9):1545-1554. doi: 10.1017/S136898001800335X. Epub 2018 Dec 6. Public Health Nutr. 2019. PMID: 30520411 Free PMC article.
References
-
- Singh GM, Danaei G, Farzadfar F, the Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group. Asia-Pacific Cohort Studies Collaboration (APCSC) the Diabetes Epidemiology: Collaborative analysis of Diagnostic criteria in Europe (DECODE) the Emerging Risk Factor Collaboration (ERFC) the Prospective Studies Collaboration (PSC) The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis. PLoS One. 2013;8:e65174. - PMC - PubMed
-
- Poirier P, Giles TD, Bray GA, the American Heart Association. the Obesity Committee of the Council on Nutrition. Physical Activity, and Metabolism Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2006;113:898–918. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous